Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 27601550)

  • 1. Timing Is Everything: What Is the Optimal Duration After Chemoradiation for Surgery for Rectal Cancer?
    Goodman KA
    J Clin Oncol; 2016 Nov; 34(31):3724-3728. PubMed ID: 27601550
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maximizing the Clinical Benefit of Anthracyclines in Addition to Taxanes in the Adjuvant Treatment of Early Breast Cancer.
    Curigliano G; Criscitiello C
    J Clin Oncol; 2017 Aug; 35(23):2600-2603. PubMed ID: 28661760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Organ Preservation in the Treatment of Stage II and III Rectal Cancer.
    Hagen ER; Cleary RK
    Dis Colon Rectum; 2020 Sep; 63(9):1185-1189. PubMed ID: 33216489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of refractory metastatic anal squamous cell carcinoma following disease progression on traditional chemoradiation therapy.
    Silva NN; Eng C
    J Adv Pract Oncol; 2012 May; 3(3):161-9. PubMed ID: 25031942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multimedia article. Laparoscopic ultralow anterior resection with colonic J-pouch-anal anastomosis.
    Selvindos PB; Ho YH
    Dis Colon Rectum; 2008 Nov; 51(11):1710-1. PubMed ID: 18679748
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concurrent Chemotherapy and Radiation Therapy for Inoperable Locally Advanced Non-Small-Cell Lung Cancer.
    Rosenzweig KE; Gomez JE
    J Clin Oncol; 2017 Jan; 35(1):6-10. PubMed ID: 27870565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune Checkpoint Blockade in PD-L1-Positive Platinum-Refractory Cervical Carcinoma.
    Tewari KS
    J Clin Oncol; 2019 Jun; 37(17):1449-1454. PubMed ID: 31026210
    [No Abstract]   [Full Text] [Related]  

  • 8. Which Patients With Cervical Squamous Cell Carcinoma Might Benefit From Neoadjuvant Chemotherapy?
    Mahmoud O; Einstein MH
    J Clin Oncol; 2018 Jun; 36(16):1543-1547. PubMed ID: 29668367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distal intramural and tumor spread in the mesorectum after neoadjuvant radiochemotherapy in rectal cancer: about 124 consecutive patients.
    Guedj N; Maggiori L; Poté N; Norkowski E; Cros J; Bedossa P; Panis Y
    Hum Pathol; 2016 Jun; 52():164-72. PubMed ID: 27210028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathologic Complete Response in Rectal Cancer: Can We Detect It? Lessons Learned From a Proposed Randomized Trial of Watch-and-Wait Treatment of Rectal Cancer.
    Nahas SC; Rizkallah Nahas CS; Sparapan Marques CF; Ribeiro U; Cotti GC; Imperiale AR; Capareli FC; Chih Chen AT; Hoff PM; Cecconello I
    Dis Colon Rectum; 2016 Apr; 59(4):255-63. PubMed ID: 26953983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advanced Epithelial Ovarian Cancer: Do More Options Mean Greater Benefits?
    Bouberhan S; Shea M; Cannistra SA
    J Clin Oncol; 2019 Jun; 37(16):1359-1364. PubMed ID: 31002579
    [No Abstract]   [Full Text] [Related]  

  • 12. Can CT replace MRI in preoperative assessment of the circumferential resection margin in rectal cancer?
    Maizlin ZV; Brown JA; So G; Brown C; Phang TP; Walker ML; Kirby JM; Vora P; Tiwari P
    Dis Colon Rectum; 2010 Mar; 53(3):308-14. PubMed ID: 20173478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision Making in a Data-Poor Environment: Management of Brain Metastases From Testicular and Extragonadal Germ Cell Tumors.
    Gilligan T
    J Clin Oncol; 2016 Feb; 34(4):303-6. PubMed ID: 26668343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. When, What, and Why of Perioperative Treatment of Potentially Curable Pancreatic Adenocarcinoma.
    Perez K; Clancy TE; Mancias JD; Rosenthal MH; Wolpin BM
    J Clin Oncol; 2017 Feb; 35(5):485-489. PubMed ID: 28029328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Duration of Anti-Programmed Death-1 Therapy in Advanced Melanoma: How Much of a Good Thing Is Enough?
    Khushalani NI
    J Clin Oncol; 2018 Jun; 36(17):1649-1653. PubMed ID: 29389234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is it time to rethink the rule of total mesorectal excision? A prospective radiological and pathological study in 49 consecutive patients with mid-rectal cancer.
    Guedj N; Zappa M; Maggiori L; Bertin C; Hennequin C; Panis Y
    Colorectal Dis; 2016 Sep; 18(9):O314-21. PubMed ID: 27381492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast Reconstruction With Postmastectomy Radiation: Choices and Tradeoffs.
    Poppe MM; Agarwal JP
    J Clin Oncol; 2017 Aug; 35(22):2467-2470. PubMed ID: 28481705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case report of pathologically complete response of rectal cancer after preoperative treatment of CPT-11, S-1, and radiation therapy].
    Hamanaka M; Yamano T; Noda M; Tsukamoto K; Kuno T; Yamagishi D; Babaya A; Matsubara N; Kamikonya N; Tomita N
    Gan To Kagaku Ryoho; 2011 Nov; 38(12):2253-5. PubMed ID: 22202346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can Stereotactic Body Radiotherapy Effectively Treat Hepatocellular Carcinoma?
    Barry A; Knox JJ; Wei AC; Dawson LA
    J Clin Oncol; 2016 Feb; 34(5):404-8. PubMed ID: 26700118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
    Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
    Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.